Risk of Stroke With Mitral Stenosis: The Underlying Mechanism, Treatment, and Prevention

Hamza Islam1, Sri Madhurima Puttagunta2, Rabia Islam1

  • 1Research, Faisalabad Medical University, Faisalabad, PAK.

Cureus
|May 6, 2022
PubMed

Insights

Mitral stenosis increases stroke risk, with mitral annular calcification being a key predictor. This review covers risk factors, assessment, and therapies including newer oral anticoagulants and non-pharmacological options for stroke prevention.

Area of Science:

  • Cardiology
  • Neurology
  • Vascular Medicine

Background:

  • Mitral stenosis (MS) involves mitral valve narrowing, increasing stroke risk.
  • Common risk factors include mitral annular calcification (MAC), diabetes mellitus (DM), hypertension (HTN), and hyperlipidemia.
  • Thrombus formation is driven by endothelial damage, hypercoagulability, and left atrial blood stasis.

Purpose of the Study:

  • To review mechanisms of thromboembolism in MS.
  • To identify stroke risk factors and assessment models in MS patients.
  • To evaluate current and novel therapies for stroke prevention in MS.

Main Methods:

  • Comprehensive literature review on MS and stroke.
  • Analysis of risk factors, including MAC as an independent predictor.
  • Evaluation of newer oral anticoagulants (NOACs) and non-pharmacological therapies.

Main Results:

  • MAC is identified as an independent predictor of stroke in MS.
  • Review encompasses mechanisms, risk factors, and assessment strategies for stroke in MS.
  • Efficacy and safety of NOACs (dabigatran, edoxaban, apixaban, rivaroxaban) and interventions like LAA ligation/occlusion are discussed.

Conclusions:

  • Understanding MS-related stroke mechanisms is crucial for risk stratification.
  • NOACs and non-pharmacological approaches offer potential for stroke risk reduction.
  • Further research on optimal therapeutic strategies is warranted.

Related Concept Videos

Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
31
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
60
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
40
Mitral Stenosis IV: Nursing Management01:27

Mitral Stenosis IV: Nursing Management

A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
58
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
38
Mitral Valve Prolapse I: Introduction01:27

Mitral Valve Prolapse I: Introduction

IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
55